HLVX
Price:
$1.9
Market Cap:
$94.59M
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2022-04-29
Stock Exchange
NASDAQ
Ticker
HLVX
According to HilleVax, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 37.22M. This represents a change of -93.18% compared to the average of 545.86M of the last 4 quarters.
The mean historical Enterprise Value of HilleVax, Inc. over the last ten years is 527.83M. The current 37.22M Enterprise Value has changed 605.24% with respect to the historical average. Over the past ten years (40 quarters), HLVX's Enterprise Value was at its highest in in the March 2024 quarter at 682.20M. The Enterprise Value was at its lowest in in the June 2021 quarter at 0.
Average
527.83M
Median
576.86M
Minimum
386.98M
Maximum
610.25M
Discovering the peaks and valleys of HilleVax, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 25.62%
Maximum Annual Enterprise Value = 610.25M
Minimum Annual Increase = -36.59%
Minimum Annual Enterprise Value = 386.98M
Year | Enterprise Value | Change |
---|---|---|
2023 | 486.11M | 25.62% |
2022 | 386.98M | -36.59% |
2021 | 610.25M | 5.41% |
2020 | 578.92M | 0.36% |
The current Enterprise Value of HilleVax, Inc. (HLVX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
494.45M
5-year avg
527.83M
10-year avg
527.83M
HilleVax, Inc.’s Enterprise Value is less than PMV Pharmaceuticals, Inc. (48.13M), less than Eliem Therapeutics, Inc. (119.64M), less than MediciNova, Inc. (38.55M), less than Pharvaris N.V. (844.48M), less than PepGen Inc. (174.61M), less than Molecular Partners AG (57.67M), less than Monte Rosa Therapeutics, Inc. (478.04M), less than Entrada Therapeutics, Inc. (540.23M), less than Vigil Neuroscience, Inc. (129.53M), less than Century Therapeutics, Inc. (121.66M), less than Edgewise Therapeutics, Inc. (3.19B), less than C4 Therapeutics, Inc. (462.75M), less than Mineralys Therapeutics, Inc. (603.45M), less than Cullinan Oncology, Inc. (810.70M), greater than Pardes Biosciences, Inc. (34.92M), greater than Shattuck Labs, Inc. (-1510332.00), less than Champions Oncology, Inc. (61.85M), less than NewAmsterdam Pharma Company N.V. (1.09B), less than Centessa Pharmaceuticals plc (1.76B), less than Sutro Biopharma, Inc. (402.09M), less than Opthea Limited (656.58M),
Company | Enterprise Value | Market cap |
---|---|---|
48.13M | $84.49M | |
119.64M | $342.68M | |
38.55M | $82.40M | |
844.48M | $1.29B | |
174.61M | $221.28M | |
57.67M | $247.30M | |
478.04M | $542.54M | |
540.23M | $661.04M | |
129.53M | $153.44M | |
121.66M | $106.74M | |
3.19B | $3.23B | |
462.75M | $455.30M | |
603.45M | $671.31M | |
810.70M | $922.99M | |
34.92M | $135.19M | |
-1510332.00 | $55.36M | |
61.85M | $57.64M | |
1.09B | $1.96B | |
1.76B | $1.80B | |
402.09M | $302.45M | |
656.58M | $628.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HilleVax, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like HilleVax, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is HilleVax, Inc.'s Enterprise Value?
What is the highest Enterprise Value for HilleVax, Inc. (HLVX)?
What is the 3-year average Enterprise Value for HilleVax, Inc. (HLVX)?
What is the 5-year average Enterprise Value for HilleVax, Inc. (HLVX)?
How does the current Enterprise Value for HilleVax, Inc. (HLVX) compare to its historical average?